The drug, which is named MariTide and delivered in a monthly injection, is years from being sold, but caused an average of up to 20 percent weight loss in a small group of patients.The drug, which is named MariTide and delivered in a monthly injection, is years from being sold, but caused an average of up to 20 percent weight loss in a small group of patients. Amgen Inc, Weight, GLP-1 RAs (Drug), Obesity, Clinical Trials, Drugs (Pharmaceuticals), your-feed-science Read More
New Amgen Drug MariTide Shows Promising Weight Loss in Early Data
